EAU Congress - Renal and Urology News

If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

EAU Annual Congress

BPH Surgery Complication Rates Underestimated

Jody A. Charnow April 30, 2012

PARIS—Complication rates after surgery for benign prostatic hyperplasia (BPH) are higher in real clinical practice than in clinical trials.

Novel Drug for Overactive Bladder Works Even If Antimuscarinics Do Not

Jody A. Charnow February 29, 2012

PARIS—Mirabegron, an experimental drug for overactive bladder (OAB), can effectively treat the condition in patients whether or not they failed previous antimuscarinic therapy, according to findings presented at the 27th Annual Congress of the European Association of Urology.

Bladder Cancer Death Risk May No Longer Be Higher in Women

Jody A. Charnow February 27, 2012

PARIS—Previous research has shown that cancer-specific survival (CSS) after radical cystectomy for bladder cancer is significantly worse for women than men, but new data presented at the 27th Annual Congress of the European Association of Urology suggest that this may no longer be the case.

Hemodialysis Patients Not More Likely to Die from Renal Cell Carcinoma

Jody A. Charnow February 27, 2012

PARIS—Hemodialysis (HD) patients are no more likely to die from renal cell carcinoma (RCC) than patients with normal renal function, but they have decreased overall survival, Japanese investigators reported at the 27th Annual Congress of the European Association of Urology.

Immediate Salvage Radiotherapy Urged for Recurrent PCa

Jody A. Charnow February 27, 2012

PARIS—Salvage radiotherapy (SRT) for recurrent prostate cancer (PCa) should be given at the earliest sign of biochemical failure, researchers reported at the 27th Annual Congress of the European Association of Urology.

Data Support Cystoscopy Prior to Brachytherapy

Jody A. Charnow February 27, 2012

PARIS—Cystoscopy prior to low dose rate (LDR) brachytherapy for prostate cancer is feasible and useful in identifying patients who require further investigation or intervention before seed implantation, researchers reported at the 27th Annual Congress of the European Association of Urology.

High-Grade Prostate Cancer Linked to Metabolic Syndrome

Jody A. Charnow February 27, 2012

PARIS—Metabolic syndrome does not increase men's risk of prostate cancer (PCa) overall, but it does increase their risk of aggressive PCa, researchers reported at the 27th Annual Congress of the European Association of Urology.

PDE-5 Inhibitors Improve LUTS in Men

Jody A. Charnow February 26, 2012

PARIS—Phosphodiesterase-5 (PDE-5) inhibitors significantly improve lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and can be considered as an alternative treatment for BPH-related LUTS in men with or without erectile dysfunction, researchers reported at the 27th Annual Congress of the European Association of Urology.

Shockwave Therapy Found to Improve Erectile Dysfunction

Jody A. Charnow February 26, 2012

PARIS—Low-intensity extracorporeal shockwave therapy (LI-ESWT) is an effective treatment option for men with vasculogenic erectile dysfunction (ED), according to findings presented at the 27th Annual Congress of the European Association of Urology.

Study: Partial Nephrectomy Complications Mostly Minor

Jody A. Charnow February 26, 2012

PARIS—Nearly one quarter of patients undergoing partial nephrectomy (PN) experience complications, but most are minor, a researcher reported at the 27th Annual Congress of the European Association of Urology.

Partial Nephrectomy Rates Rise, but Disparities Exist

Jody A. Charnow February 26, 2012

PARIS—Partial nephrectomy (PN) rates have increased dramatically, but this surgical approach is underused in certain patient populations, according to data presented at the 27th Annual Congress of the European Association of Urology.

NSAID Use May Increase Prostate Cancer Risk

Jody A. Charnow February 25, 2012

PARIS—Contrary to the findings of previous epidemiologic studies, a new study found that use of nonsteroidal anti-inflammatory agents (NSAIDs) is associated with an increased risk of prostate cancer (PCa) overall and aggressive PCa, Finnish researchers reported at the 27th Annual Congress of the European Association of Urology.

Metabolic Syndrome Raises BPH Risk

Jody A. Charnow February 25, 2012

PARIS—Metabolic syndrome increases a man's risk of developing benign prostatic hyperplasia (BPH) and the risk of prostatic inflammation in men who have BPH, according to reports at the 27th Annual Congress of the European Association of Urology.

Prophylactic Antibiotics Unnecessary for Outpatient Cystoscopy

Jody A. Charnow February 25, 2012

PARIS—Antibiotic prophylaxis and risk-based stratification are unnecessary for most patients undergoing outpatient flexible cystoscopy, researchers reported at the 27th Annual Congress of the European Association of Urology.

Renal Dysfunction After Radical Nephrectomy Raises Cardiovascular Risks

Jody A. Charnow February 25, 2012

PARIS—Renal dysfunction following radical nephrectomy (RN) for renal cancer is associated with an increased risk of cardiovascular (CV) events and non-cancer-related mortality, Japanese researchers reported at the 27th Annual Congress of the European Association of Urology.

Post-Prostate Biopsy Infections a Significant Global Problem

Jody A. Charnow February 25, 2012

PARIS—Infectious complications following a transrectal prostate biopsy have become a significant health problem globally, data presented at the 27th Annual Congress of the European Association of Urology suggest.

Flexible Ureteroscopy Suitable for Obese Stone Patients

Jody A. Charnow February 25, 2012

PARIS—Flexible ureteroscopy can be an effective treatment for kidney stones in obese and overweight patients, according to data presented at the 27th Annual Congress of the European Association of Urology. The procedure is associated with a low complication rate in these patients, according to researchers.

Botulinum Toxin Eases LUTS in Men

Jody A. Charnow March 22, 2011

VIENNA—Botulinum toxin type A (BTA) injected into the prostate may be a safe and effective treatment for lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH), according to preliminary study results presented here at the 26th Annual Congress of the European Association of Urology.

Novel Cause of BPH, PCa Proposed

Jody A. Charnow March 22, 2011

VIENNA—Benign prostatic hyperplasia (BPH) and prostate cancer could be the result a previously unrecognized route of free testosterone flow from the testes to the prostate, according to investigators.

Real-Time Elastography Superior for Identifying Prostate Cancer

Jody A. Charnow March 22, 2011

VIENNA—Real-time elastography has significantly better predictive accuracy for identifying prostate cancer (PCa) lesions compared with contrast-enhanced magnetic resonance imaging (MRI), researchers reported here at the 26th Annual Congress of the European Association of Urology. Biopsy studies need to confirm these results, however.

Interview with Wolfgang Otto, MD: Play

Interview with Yoram Vardi, MD: Play

Interview with Maxine Sun, PhD: Play

Interview with Hervé Baumert, MD, PhD: Play

Interview with Nicholas J. Mehan, MD: Play

Interview with Vikram Khullar, MBBS: Play

Your Practice

The move from ICD-9-CM to ICD-10 is enough to strike fear into the hearts of physicians and staff alike. Making the leap from 14,000 codes to almost 69,000, topped with the huge cost to make that change, is understandably daunting.

Read more on
Coping with ICD-10

Have any practice management topics that you'd like us to cover?
Let us know.

Legal Issues

After Radical Prostatectomy, Patient Learns He Never Had Prostate Cancer

Is honesty always the best policy? That is the question that a urologist had to grapple with in this case.

Your Money

In recent months, investors have been eagerly pursuing shares of Facebook, Groupon, and other hot technology companies. That has led some Wall Street analysts to worry that the stocks in the sector could be overheated and poised to sink.

Read more on
Bargain Price Stocks for Technology Companies